Inicio
Detalle del título uniforme
Cureus
Tipo de obra :
Autre
Naturaleza de la obra :
Oeuvre
|
Documentos disponibles con este título uniforme (6)
Clasificado(s) por (Año de edición descendente) Refinar búsquedaCardio-oncology clinical assessment and screening in patients undergoing high toxicity chemotherapy: a retrospective cohort study / Andrés Felipe Miranda Arboleda ; Juan Guillermo Gamboa Arroyave
Título : Cardio-oncology clinical assessment and screening in patients undergoing high toxicity chemotherapy: a retrospective cohort study Tipo de documento : documento electrónico Autores : Andrés Felipe Miranda Arboleda, ; Juan Guillermo Gamboa Arroyave, Fecha de publicación : 2022 Títulos uniformes : Cureus Idioma : Inglés (eng) Palabras clave : cardio-oncology solid tumors hematological malignancies chemotherapy cardiotoxicity Resumen : Objective: To describe the clinical characteristics and cardio-oncological assessment in patients undertaking highly toxic chemotherapy and/or chest radiotherapy in a high-complexity hospital. Methods: A single-center retrospective cohort study was carried out between January 1st, 2017 and December 31st, 2019. The medical records of patients with solid or hematological neoplasms were reviewed. Descriptive information was obtained on demographic characteristics, chemotherapeutic agents, pre-chemotherapy cardiovascular (CV) evaluation, and CV outcomes. The risk of complications was assessed using the Mayo Clinic risk score. Results: A total of 499 patients were included, the most common neoplasm was non-Hodgkin's lymphoma (21.6%), followed by breast cancer (19.4%). A very high risk of cardiotoxicity was present in 44.1% and 90% were not evaluated by cardiology. Pre-chemotherapy echocardiography was obtained in 65%, but only 19.4% underwent echocardiographic control after finishing chemotherapy. The most frequent CV outcomes were chemotherapy-related systolic dysfunction (4.4%) and rhythm disturbances (2.8%), with atrial fibrillation and atrial flutter being the most frequent arrhythmias. Conclusion: Despite the recognized CV toxicity of chemotherapeutic drugs, the majority of patients receiving highly toxic regimens at high risk of CV complications are not previously evaluated by a cardiologist and the CV workup was not routinely used in our study. The implementation of cardio-oncology programs will facilitate the identification of high-risk patients, aiming to detect and treat complications early. Mención de responsabilidad : Carlos A. Regino, Jonathan Cardona-Vélez, Jesus D. Bello Simanca, Andres F. Miranda Arboleda, Juan G. Gamboa Arroyave, Fabian Jaimes DOI (Digital Object Identifier) : 10.7759/cureus.32513 Derechos de uso : CC BY En línea : https://www.cureus.com/articles/127878-cardio-oncology-clinical-assessment-and-s [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_dis Cardio-oncology clinical assessment and screening in patients undergoing high toxicity chemotherapy: a retrospective cohort study [documento electrónico] / Andrés Felipe Miranda Arboleda, ; Juan Guillermo Gamboa Arroyave, . - 2022.
Obra : Cureus
Idioma : Inglés (eng)
Palabras clave : cardio-oncology solid tumors hematological malignancies chemotherapy cardiotoxicity Resumen : Objective: To describe the clinical characteristics and cardio-oncological assessment in patients undertaking highly toxic chemotherapy and/or chest radiotherapy in a high-complexity hospital. Methods: A single-center retrospective cohort study was carried out between January 1st, 2017 and December 31st, 2019. The medical records of patients with solid or hematological neoplasms were reviewed. Descriptive information was obtained on demographic characteristics, chemotherapeutic agents, pre-chemotherapy cardiovascular (CV) evaluation, and CV outcomes. The risk of complications was assessed using the Mayo Clinic risk score. Results: A total of 499 patients were included, the most common neoplasm was non-Hodgkin's lymphoma (21.6%), followed by breast cancer (19.4%). A very high risk of cardiotoxicity was present in 44.1% and 90% were not evaluated by cardiology. Pre-chemotherapy echocardiography was obtained in 65%, but only 19.4% underwent echocardiographic control after finishing chemotherapy. The most frequent CV outcomes were chemotherapy-related systolic dysfunction (4.4%) and rhythm disturbances (2.8%), with atrial fibrillation and atrial flutter being the most frequent arrhythmias. Conclusion: Despite the recognized CV toxicity of chemotherapeutic drugs, the majority of patients receiving highly toxic regimens at high risk of CV complications are not previously evaluated by a cardiologist and the CV workup was not routinely used in our study. The implementation of cardio-oncology programs will facilitate the identification of high-risk patients, aiming to detect and treat complications early. Mención de responsabilidad : Carlos A. Regino, Jonathan Cardona-Vélez, Jesus D. Bello Simanca, Andres F. Miranda Arboleda, Juan G. Gamboa Arroyave, Fabian Jaimes DOI (Digital Object Identifier) : 10.7759/cureus.32513 Derechos de uso : CC BY En línea : https://www.cureus.com/articles/127878-cardio-oncology-clinical-assessment-and-s [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_dis Reserva
Reservar este documento
Ejemplares (1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD001920 AC-2022-084 Archivo digital Producción Científica Artículos científicos Disponible Documentos electrónicos
AC-2022-084Adobe Acrobat PDF
Título : Ovarian epithelioid hemangioendothelioma in a pediatric patient: a case report Tipo de documento : documento electrónico Autores : Jorge Alberto Ochoa Gaviria, Fecha de publicación : 2022 Títulos uniformes : Cureus Idioma : Inglés (eng) Palabras clave : pediatric epithelioid hemangioendothelioma ovaries vascular tumors childhood ovarian neoplasm mri pelvis pelvic ultrasonography Resumen : We present a case of an eight-month-old girl who was brought to the emergency department with bloody stools. An initial ultrasound reported a mass in the left iliac fossa that was further characterized by magnetic resonance imaging (MRI) as a hypervascular ovarian tumor. Prior to surgical resection of the tumor, abdominal arteriography with selective embolization and vessel occlusion was performed. Pathology reported epithelioid hemangioendothelioma of the left ovary. This condition has not been previously reported in girls. In this case report, we describe the ultrasound, MRI, and arteriographic findings with a histopathologic correlation of an adnexal tumor that is unknown in the pediatric female population until now. Mención de responsabilidad : Brian D. Noreña-Rengifo, Mónica Royero-Arias, Antonella Arrieta-Rojano, Jorge Ochoa-Gaviria, Abraham Chams-Anturi Referencia : Cureus. 2022 Feb 24;14(2):e22556. DOI (Digital Object Identifier) : 10.7759/cureus.22556 PMID : 35371823 Derechos de uso : CC BY En línea : https://www.cureus.com/articles/82365-ovarian-epithelioid-hemangioendothelioma-i [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_dis Ovarian epithelioid hemangioendothelioma in a pediatric patient: a case report [documento electrónico] / Jorge Alberto Ochoa Gaviria, . - 2022.
Obra : Cureus
Idioma : Inglés (eng)
Palabras clave : pediatric epithelioid hemangioendothelioma ovaries vascular tumors childhood ovarian neoplasm mri pelvis pelvic ultrasonography Resumen : We present a case of an eight-month-old girl who was brought to the emergency department with bloody stools. An initial ultrasound reported a mass in the left iliac fossa that was further characterized by magnetic resonance imaging (MRI) as a hypervascular ovarian tumor. Prior to surgical resection of the tumor, abdominal arteriography with selective embolization and vessel occlusion was performed. Pathology reported epithelioid hemangioendothelioma of the left ovary. This condition has not been previously reported in girls. In this case report, we describe the ultrasound, MRI, and arteriographic findings with a histopathologic correlation of an adnexal tumor that is unknown in the pediatric female population until now. Mención de responsabilidad : Brian D. Noreña-Rengifo, Mónica Royero-Arias, Antonella Arrieta-Rojano, Jorge Ochoa-Gaviria, Abraham Chams-Anturi Referencia : Cureus. 2022 Feb 24;14(2):e22556. DOI (Digital Object Identifier) : 10.7759/cureus.22556 PMID : 35371823 Derechos de uso : CC BY En línea : https://www.cureus.com/articles/82365-ovarian-epithelioid-hemangioendothelioma-i [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_dis Reserva
Reservar este documento
Ejemplares (1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD001972 AC-2022-124 Archivo digital Producción Científica Artículos científicos Disponible Documentos electrónicos
AC-2022-124Adobe Acrobat PDF
Título : Preoperative embolization of a giant solitary fibrous tumor of the pleura: a case report Tipo de documento : documento electrónico Autores : José Miguel Hidalgo Oviedo, Fecha de publicación : 2022 Títulos uniformes : Cureus Idioma : Inglés (eng) Palabras clave : case report thoracotomy therapeutic embolization pleural solitary fibrous tumor Resumen : Only 5% of pleural neoplasms are fibrous tumors of the pleura, which typically develop from sub-mesothelial mesenchymal tissue of the visceral pleura. These tumors often behave clinically benignly, and when they are larger than 15 cm or occupy more than 40% of the hemithorax, they are referred to as “giant” tumors. Surgical excision is the gold standard treatment, although intra-operative bleeding is one of the major complications. In this case report, we discuss a 39-year-old female patient with a large homogeneous enhancing mass of soft tissue density in the right lower hemithorax with systemic arterial supply from the right inferior phrenic artery. Angiography and embolization were valuable adjuncts in preoperative management. Via thoracotomy, the mass was successfully removed completely with minimal blood loss. Giant SFTP is a rare neoplasm of the pleura. Intraoperative bleeding is one of the main complications during surgical resection, which is the gold standard of its treatment. Angiography and embolization are valuable complements in the preoperative treatment of this type of tumors to reduce intraoperative blood loss and operative times. Mención de responsabilidad : Johan Sebastian Lopera Valle, David Jiménez Marín, José Miguel Hidalgo Oviedo Referencia : Cureus. 2022 Oct 11;14(10):e30173. DOI (Digital Object Identifier) : 10.7759/cureus.30173 PMID : 36397891 Derechos de uso : CC BY En línea : https://www.cureus.com/articles/92324-preoperative-embolization-of-a-giant-solit [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_dis Preoperative embolization of a giant solitary fibrous tumor of the pleura: a case report [documento electrónico] / José Miguel Hidalgo Oviedo, . - 2022.
Obra : Cureus
Idioma : Inglés (eng)
Palabras clave : case report thoracotomy therapeutic embolization pleural solitary fibrous tumor Resumen : Only 5% of pleural neoplasms are fibrous tumors of the pleura, which typically develop from sub-mesothelial mesenchymal tissue of the visceral pleura. These tumors often behave clinically benignly, and when they are larger than 15 cm or occupy more than 40% of the hemithorax, they are referred to as “giant” tumors. Surgical excision is the gold standard treatment, although intra-operative bleeding is one of the major complications. In this case report, we discuss a 39-year-old female patient with a large homogeneous enhancing mass of soft tissue density in the right lower hemithorax with systemic arterial supply from the right inferior phrenic artery. Angiography and embolization were valuable adjuncts in preoperative management. Via thoracotomy, the mass was successfully removed completely with minimal blood loss. Giant SFTP is a rare neoplasm of the pleura. Intraoperative bleeding is one of the main complications during surgical resection, which is the gold standard of its treatment. Angiography and embolization are valuable complements in the preoperative treatment of this type of tumors to reduce intraoperative blood loss and operative times. Mención de responsabilidad : Johan Sebastian Lopera Valle, David Jiménez Marín, José Miguel Hidalgo Oviedo Referencia : Cureus. 2022 Oct 11;14(10):e30173. DOI (Digital Object Identifier) : 10.7759/cureus.30173 PMID : 36397891 Derechos de uso : CC BY En línea : https://www.cureus.com/articles/92324-preoperative-embolization-of-a-giant-solit [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_dis Reserva
Reservar este documento
Ejemplares (1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD001971 AC-2022-123 Archivo digital Producción Científica Artículos científicos Disponible Documentos electrónicos
AC-2022-123Adobe Acrobat PDF
Título : Hemolysis in Hemodialysis, Secondary to Severe Vena Cava Stenosis Tipo de documento : documento electrónico Autores : Dahyana Cadavid Aljure, ; Sergio Álvarez Vallejo, ; Gloria María Posada Álvarez, ; Eliana María Ruiz Aguilar, ; Lina Marcela Higuita Urrego, ; Catalina María Guerra Álvarez, ; Sandra Marcela Marín Durango, ; Catalina Ocampo Kohn, ; John Fredy Nieto Ríos, ; Arbey Aristizabal Álzate, ; Gustavo Adolfo Zuluaga Valencia, Fecha de publicación : 2021 Títulos uniformes : Cureus Idioma : Inglés (eng) Palabras clave : hemolysis anemia hemodialysis access stenosis blood circulation complications Resumen : Complications in hemodialysis patients are increasingly rare thanks to advances in technology, including more compatible membranes, more flexible lines, safety in water treatments, alarms in the circuit, and standardization in dialysate fluids plus exhaustive chemical and microbiological tests. In addition, it is highly unusual having hemolysis on hemodialysis; however, it is a life-threatening complication, so the cause must be identified and early managed. The etiology can be chemical or mechanical; however, so far, there are no reports in the literature of an association with severe stenosis of the vena cava, as it is described in the case reported here, where a patient presented hemolysis in two hemodialysis sessions, without initially being possible to find the cause; the only identifiable factor was that he had a dysfunctional tunneled jugular catheter, with a history of difficult vascular access. The patient underwent interventional radiology, finding 99% stenosis of the vena cava, which prevented the passage of the contrast agent to the atrium. Angioplasty and catheter replacement were performed, with a resolution of the complication; the subsequent dialysis therapies were satisfactory. Mención de responsabilidad : Dahyana Cadavid Aljure, Sergio Alvarez-Vallejo, Gloria Posada-Alvarez, Eliana Ruiz-Aguilar, Lina Higuita-Urrego, Catalina Guerra-Alvarez, Sandra Marin-Durango, Catalina Ocampo-Kohn, John Fredy Nieto-Rios, Arbey Aristizabal-Alzate, Gustavo Zuluaga-Valencia Referencia : Cureus. 2021 May 21;13(5):e15156. DOI (Digital Object Identifier) : 10.7759/cureus.15156 PMID : 34168923 En línea : https://www.cureus.com/articles/58087-hemolysis-in-hemodialysis-secondary-to-sev [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_dis Hemolysis in Hemodialysis, Secondary to Severe Vena Cava Stenosis [documento electrónico] / Dahyana Cadavid Aljure, ; Sergio Álvarez Vallejo, ; Gloria María Posada Álvarez, ; Eliana María Ruiz Aguilar, ; Lina Marcela Higuita Urrego, ; Catalina María Guerra Álvarez, ; Sandra Marcela Marín Durango, ; Catalina Ocampo Kohn, ; John Fredy Nieto Ríos, ; Arbey Aristizabal Álzate, ; Gustavo Adolfo Zuluaga Valencia, . - 2021.
Obra : Cureus
Idioma : Inglés (eng)
Palabras clave : hemolysis anemia hemodialysis access stenosis blood circulation complications Resumen : Complications in hemodialysis patients are increasingly rare thanks to advances in technology, including more compatible membranes, more flexible lines, safety in water treatments, alarms in the circuit, and standardization in dialysate fluids plus exhaustive chemical and microbiological tests. In addition, it is highly unusual having hemolysis on hemodialysis; however, it is a life-threatening complication, so the cause must be identified and early managed. The etiology can be chemical or mechanical; however, so far, there are no reports in the literature of an association with severe stenosis of the vena cava, as it is described in the case reported here, where a patient presented hemolysis in two hemodialysis sessions, without initially being possible to find the cause; the only identifiable factor was that he had a dysfunctional tunneled jugular catheter, with a history of difficult vascular access. The patient underwent interventional radiology, finding 99% stenosis of the vena cava, which prevented the passage of the contrast agent to the atrium. Angioplasty and catheter replacement were performed, with a resolution of the complication; the subsequent dialysis therapies were satisfactory. Mención de responsabilidad : Dahyana Cadavid Aljure, Sergio Alvarez-Vallejo, Gloria Posada-Alvarez, Eliana Ruiz-Aguilar, Lina Higuita-Urrego, Catalina Guerra-Alvarez, Sandra Marin-Durango, Catalina Ocampo-Kohn, John Fredy Nieto-Rios, Arbey Aristizabal-Alzate, Gustavo Zuluaga-Valencia Referencia : Cureus. 2021 May 21;13(5):e15156. DOI (Digital Object Identifier) : 10.7759/cureus.15156 PMID : 34168923 En línea : https://www.cureus.com/articles/58087-hemolysis-in-hemodialysis-secondary-to-sev [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_dis Reserva
Reservar este documento
Ejemplares (1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD001731 AC-2021-050 Archivo digital Producción Científica Artículos científicos Disponible
Título : Renal medullary carcinoma in an adolescent with unknown sickle cell trait Tipo de documento : documento electrónico Autores : Jorge Alberto Ochoa Gaviria, ; Alejandro Vélez Escobar, ; Juan Pablo Muñoz Rengifo, ; Marcela Riveros Ángel, Fecha de publicación : 2021 Títulos uniformes : Cureus Idioma : Inglés (eng) Palabras clave : body mri child and adolescent renal neoplasm sickle cell trait renal medullary carcinoma Resumen : Renal medullary carcinoma (RMC) is an aggressive and rare malignancy that usually presents in adolescents and young adults with sickle cell disease. Herein, we describe a case of a white male with an unknown sickle cell trait, who presented with left iliac fossa pain, without any other finding that suggested renal neoplasia. Imaging findings were a renal mass of central location with caliectasis, renal hilar adenopathy, and paraaortic lymphadenopathy. Biopsy confirmed an RMC diagnosis. RMC diagnosis requires clinical suspicion in sickle cell patients who present with pain and hematuria. Imaging shows a central mass, with an infiltrative appearance, frequently associated with calyx’s dilation and lymphadenopathy. Prognosis is poor in spite of the treatment. Mención de responsabilidad : Brian D. Noreña-Rengifo, Jorge Ochoa-Gaviria, Alejandro Vélez-Escobar, Juan P. Muñoz, Marcela Riveros-Ángel Referencia : Cureus. 2021 Apr 13;13(4):e14473. DOI (Digital Object Identifier) : 10.7759/cureus.14473 PMID : 33996332 Derechos de uso : CC BY En línea : https://www.cureus.com/articles/55673-renal-medullary-carcinoma-in-an-adolescent [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_dis Renal medullary carcinoma in an adolescent with unknown sickle cell trait [documento electrónico] / Jorge Alberto Ochoa Gaviria, ; Alejandro Vélez Escobar, ; Juan Pablo Muñoz Rengifo, ; Marcela Riveros Ángel, . - 2021.
Obra : Cureus
Idioma : Inglés (eng)
Palabras clave : body mri child and adolescent renal neoplasm sickle cell trait renal medullary carcinoma Resumen : Renal medullary carcinoma (RMC) is an aggressive and rare malignancy that usually presents in adolescents and young adults with sickle cell disease. Herein, we describe a case of a white male with an unknown sickle cell trait, who presented with left iliac fossa pain, without any other finding that suggested renal neoplasia. Imaging findings were a renal mass of central location with caliectasis, renal hilar adenopathy, and paraaortic lymphadenopathy. Biopsy confirmed an RMC diagnosis. RMC diagnosis requires clinical suspicion in sickle cell patients who present with pain and hematuria. Imaging shows a central mass, with an infiltrative appearance, frequently associated with calyx’s dilation and lymphadenopathy. Prognosis is poor in spite of the treatment. Mención de responsabilidad : Brian D. Noreña-Rengifo, Jorge Ochoa-Gaviria, Alejandro Vélez-Escobar, Juan P. Muñoz, Marcela Riveros-Ángel Referencia : Cureus. 2021 Apr 13;13(4):e14473. DOI (Digital Object Identifier) : 10.7759/cureus.14473 PMID : 33996332 Derechos de uso : CC BY En línea : https://www.cureus.com/articles/55673-renal-medullary-carcinoma-in-an-adolescent [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_dis Reserva
Reservar este documento
Ejemplares (1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD001697 AC-2021-022 Archivo digital Producción Científica Artículos científicos Disponible Documentos electrónicos
2021-022Adobe Acrobat PDF
Permalink
